Voriconazole Tablets, 50 mg recall — FDA D-0307-2025
cGMP Deviations: Received notification from their supplier requesting they perform a recall due to the fact they repackaged the product.
Complete FDA and NHTSA recall records dated in 2025, organized for browsing by month, category and recalling company.
Select a month to review the recall records reported during that period.
Records are ordered by the best available source date.
cGMP Deviations: Received notification from their supplier requesting they perform a recall due to the fact they repackaged the product.
Sub-Potent Drug: The stability batch showed a subpotent result, which does not meet the product specifications of 90.0-110.0% of the label claim.
Failed Dissolution Specifications: Out of specification results obtained during routine stability testing for dissolution.
Lack of Assurance of Sterility
Failed stability specifications: during routine stability monitoring quality concerns were identified. Physical separation for ingredients was observed.
Microbial Contamination of Non-Sterile Products: Bacterial contamination with Staphylococcus aureus
Lack of Assurance of Sterility
Microbial Contamination of Non-Sterile Products: Bacterial contamination with Staphylococcus aureus
Microbial Contamination of Non-Sterile Products: Bacterial contamination with Staphylococcus aureus
Lack of Assurance of Sterility
Labeling; Label Mixup; some bottles have an incorrect back label indicating 91% Isopropyl Alcohol
Lack of Assurance of Sterility
BMW of North America, LLC (BMW) is recalling certain 2025 330i, 330i xDrive, 530i, 530i xDrive, 4 Series Coupe (430i, 430i xDrive), 4 Series Convertible (430i, 430i xDrive), 4 Series Gran…
Ford Motor Company (Ford) is recalling certain 2024-2025 F-150, Expedition, and 2024 Lincoln Navigator vehicles equipped with 3.5L GTDI engines. The engine may have a misaligned engine cup…
CGMP deviations: The presence of nitrosamine impurity above the acceptable daily intake limits.
Super-Potent Drug: Out of specification potency results were obtained.
Stability data does not support expiry: the products have the potential to be out of specification at the time of expiry of 36-months.
CGMP deviations: The presence of nitrosamine impurity above the acceptable daily intake limits.
Super-Potent Drug: Out of specification potency results were obtained.
Defective container: Unable to get the solution out of the bottle as the spike of the cap was lodged in the nozzle of the product bottle
Stability data does not support expiry: the products have the potential to be out of specification at the time of expiry of 36-months.
Tesla, Inc. (Tesla) is recalling certain 2021-2024 Model S and 2021-2025 Model X vehicles. An air bag with the incorrect horn pad may have been installed, preventing the horn from sounding.
CGMP Deviations
Non-Sterility: contamination of Aspergillus penicillioides, due to breach in package lidding.
This archive groups records by their reported or recall date. It does not imply that every recall was initiated, announced and resolved during the same calendar year. Open the individual record for the exact dates and source details supplied by FDA or NHTSA.